1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Group 2 Pulmonary Hypertension: new trials by email Literature Review of Group 2 Pulmonary Hypertension trials Research Report on Group 2 Pulmonary Hypertension
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension JK07 - HFrEF - Heart Failure With Reduced Ejection Fraction, HFpEF - Heart Failure With Preserved Ejection Fraction | Phase 2 | Withdrawn | Salubris Biotherapeutics Inc | 2025-12-15 | 2026-05-15 |
Fibromatosis, Gingival, 2 (1) · Heart Failure (1) · Heart Failure, Diastolic (1) · Heart Failure, Systolic (1) · Hypertension, Pulmonary (1)
Cardiovascular Diseases (1) · Heart Diseases (1) · Hypertension (1) · Lung Diseases (1) · Respiratory Tract Diseases (1) · Vascular Diseases (1)
Salubris Biotherapeutics Inc (1)
United States (1)